The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes
Open accessAbstract
OBJECTIVE: The liver-secreted protein fetuin-A induces insulin resistance in animals, and circulating fetuin-A is elevated in insulin resistance and fatty liver in humans. We investigated whether plasma fetuin-A levels predict the incidence of type 2 diabetes in a large prospective, population-based study. RESEARCH DESIGN AND METHODS: A case-cohort study within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study comprising 27,548 subjects was designed. We randomly selected a subcohort of 2,500 individuals of whom 2,164 were diabetes free at baseline and had anamnestic, anthropometrical, and metabolic data for analysis. Of the 849 incident diabetic case subjects identified in the full cohort during 7 years of follow-up, 703 remained for analyses after similar exclusions. RESULTS: Plasma fetuin-A levels were positively associated with diabetes risk after adjustment for age (relative risk [RR] for extreme quintiles 1.75 [95% CI 1.32-2.31]; RR for 10 mug/ml 1.04 [1.03-1.06]). The association remained significant after adjustment for sex, BMI, waist circumference, and lifestyle risk factors (RR for 10 mug/ml 1.03 [1.01-1.06]). Adjustment for glucose, triglycerides, HDL cholesterol, A1C, gamma-glutamyltransferase, or high-sensitivity C-reactive protein or mutual adjustment for these biomarkers did not appreciably change this result (RR for 10 mug/ml full adjusted model 1.05 [1.02-1.07]). Furthermore, fetuin-A was associated with increased diabetes risk particularly in individuals with elevated plasma glucose. CONCLUSIONS: Our data suggest that fetuin-A is an independent risk factor of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Notably, its levels have been found increased in obesity, especially associated with NAFLD [137], and are predictive for the development of T2DM [190].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Type 2 diabetes: principles of pathogenesis and therapy
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J. E., Carnes, B. A., Brody, J. A., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000167407.83915.e7 · Cited by 1,947
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,658
A Case-Cohort Design for Epidemiologic Cohort Studies and Disease Prevention Trials
Prentice, R. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.1 · Cited by 1,444
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,138
Adiponectin and protection against type 2 diabetes mellitus
Spranger, J., Kroke, A., Möhlig, M., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12255-6 · Cited by 1,120
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–379 of 379
Jemal, M., Waritu, N. C., Baylie, T., Sinamaw, D., Mengistu, E. F., Osman, E. E., Baye, G., Tegegne, B. A., Amare, G. A., Teffera, Z. H., et al. (2025) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223251389795 · Cited by 3
Gestational Diabetes and the Metabolic Syndrome
Souza, L. R. D., Joël, G., & Retnakar, R. (2011) · InTech eBooks · doi:10.5772/22119 · Cited by 3
Understanding the Effects of Fetuin-A in Pregnancy
Gomez, L. M. (2013) · Cited by 3
Högstedt, A., Farnebo, S. J., Tesselaar, E., & Ghafouri, B. (2021) · Scientific Reports · doi:10.1038/s41598-021-98672-8 · Cited by 3
Fetuin-A levels in diabetic retinopathy: a systematic review and meta-analysis
Behnoush, A. H., Samavarchitehrani, A., Ghaleno, A. M. S., & Klisic, A. N. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01533-0 · Cited by 3
Hamouda, H. (2015) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2015.02.00053 · Cited by 3
Elbahr, O. D., Saleh, A. A., & Bakery, L. H. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100607 · Cited by 3
Biological Markers of Insulin Sensitivity Links with Dietary Antioxidant
Bohórquez-Medina, A. L., Bohórquez-Medina, S. L., & Benites-Zapata, V. A. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_10-1 · Cited by 3
Beigi, T., Shafaei, A., Khoshnia, M., & Marjani, A. (2015) · Journal of Medical Sciences(Faisalabad) · doi:10.3923/jms.2015.229.234 · Cited by 3
Ențuc, M., Bogdán, M., Boboc, I. K. Ş., Mititelu-Tarțău, L., Reurean‐Pintilei, D., Pavel, L. L., Pelin, A.-M., Spinei, A., & Foia, L. G. (2026) · Medicina · doi:10.3390/medicina62010152 · Cited by 3
Jo, H. J., Kim, A., Rho, H., Park, A. K., Kim, G.-H., Jo, S. J., Yuxin, H., Hong, Y.-J., Yeon, J. M., Yu, H. C., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci196374 · Cited by 2
Analyse des calcifications chez les patients ayant une atteinte coralliforme de l’aorte
Schlieper, G., Grotemeyer, D., Aretz, A., Schurgers, L. J., Krüger, T., Rehbein, H., Weirich, T. E., Westenfeld, R., Brandenburg, V. M., Eitner, F., et al. (2010) · Annales de Chirurgie Vasculaire · doi:10.1016/j.acvfr.2010.10.006 · Cited by 2
Medicine-based evidence: reverse translational ear research recommendations.
Brookler, K. H. (2009) · PubMed · Cited by 2
Sağ, S., GÜZEL, D., SAĞ, M. S., Tekeoğlu, İ., KAMANLI, A., Nas, K., & Doğanay, S. (2019) · Archives of Rheumatology · doi:10.5606/archrheumatol.2019.6722 · Cited by 2
Stefan, N. (2020) · Diabetes Mellitus · doi:10.14341/dm10376 · Cited by 2
Self-citationReichert, E., Mosiewicz, J., Myśliński, W., Jaroszyński, A., Stanek, A., Brożyna-Tkaczyk, K., & Mosiewicz-Madejska, B. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116422 · Cited by 2
Reichmann, R., Schulze, M. B., Pischon, T., Weikert, C., & Aleksandrova, K. (2024) · Age and Ageing · doi:10.1093/ageing/afae041 · Cited by 3
Self-citationLipid-Induced Insulin Resistance
Mukhopadhyay, S., Dutta, D., & Ganguly, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812019-4.00014-3 · Cited by 2
Eckel, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809518-8.00005-2 · Cited by 1
Hirako, S., Wada, N., Iizuka, Y., Hirabayashi, T., Kageyama, H., Kim, H., Kaibara, N., Yanagisawa, N., Takenoya, F., & Shioda, S. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02200-y · Cited by 1
Rani, A., Singh, L., Chakraborti, A., Gupta, S., Singh, H., & Toor, D. (2024) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/02184923241306482 · Cited by 1
Bourebaba, L., Panek, M., Piedra, L. C. C., & Bourebaba, N. (2025) · Veterinary Research Communications · doi:10.1007/s11259-025-10926-2 · Cited by 1
Khan, H., Parmar, V., Khan, M. M., Khan, S., & Alam, R. (2025) · Cureus · doi:10.7759/cureus.95914 · Cited by 1
Chymase and Fetuin-A in Metabolic Inflammation: Molecular Pathways Linking to Insulin Resistance
Öner-İyidoğan, Y., & Koçak, H. (2026) · Diabetology · doi:10.3390/diabetology7020033 · Cited by 1
Milani, I., Ciasca, G., Chinucci, M., Carnazzo, V., Leonetti, F., Basile, U., & Capoccia, D. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02880-w · Cited by 1
Contrôle de la signalisation et de l’action de l’insuline par la protéine Grb14
Gondoin, A., Morzyglod, L., Desbuquois, B., & Burnol, A. (2014) · Biologie Aujourd hui · doi:10.1051/jbio/2014013 · Cited by 1
Clinical Implications of Serum Biomarkers in Diabetic Cardiovascular Complications
Son, J. W., & Kwon, H. (2009) · Korean Diabetes Journal · doi:10.4093/kdj.2009.33.5.363 · Cited by 1
Syoufi, I., Koška, J., Budoff, M. J., & Reaven, P. D. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0065 · Cited by 1
Doğru, Y., Büyükyazı, G., Ulman, C., Taneli, F., Tıkız, H., Göral, M., & Esen, H. (2016) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2016-0047 · Cited by 1
Hailin, L., & Xinhua, X. (2014) · Cited by 1
The Answer to Why Some Are Obese but Healthy?!
Dv, M. (2018) · Journal of Obesity and Chronic Diseases · doi:10.17756/jocd.2018-016 · Cited by 1
Mahmmoed, B. J., Hilal, N. N., & Sarhat, E. R. (2023) · South Asian Research Journal of Pharmaceutical Sciences · doi:10.36346/sarjps.2023.v05i04.011 · Cited by 1
Obesity-mediated insulin resistance in target tissues: role of adiponectin, fetuin-A, and irisin
Mukherjee, S., Das, S., Chattopadhyay, D., & Mukhopadhyay, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00041-4 · Cited by 2
Serum Levels of FABP4 and Fetuin-A as Potential Biomarkers in Thyroid Diseases: A Comparative Study
Lafta, B. T., Aubaid, S. H., & Falih, E. S. (2025) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v8i2(special).1362 · Cited by 1
Fetuin-A: A Biomarker for Type II Diabetes Mellitus
Udeh, C. L. (2017) · International Journal of Biomedical Materials Research · doi:10.11648/j.ijbmr.20170506.12 · Cited by 1
Association of Fetuin-A with Carotid Intima-Media Thickness and Vascular Diseases
Akyüz, A. (2016) · Springer eBooks · doi:10.1007/978-94-007-7678-4_16 · Cited by 1
Zarfeshani, A. (2016) · Journal of Obesity and Bariatrics · doi:10.13188/2377-9284.1000018 · Cited by 1
Biological Markers of Insulin Sensitivity Links with Dietary Antioxidant
Bohórquez-Medina, A. L., Bohórquez-Medina, S. L., & Benites-Zapata, V. A. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_10 · Cited by 1
Raynor, L. A. (2011) · University of Minnesota Digital Conservancy (University of Minnesota)
Boeing, H. (2009) · doi:10.1002/9783527626588.ch22
Self-citationHimmetoğlu, Ş., Arı, O., YAKICI, A., Koldaş, L., & Dinçer, Y. (2015) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2013-38201
Association of Fetuin-A Level and Diabetes Risk—Reply
Ix, J. H. (2008) · JAMA · doi:10.1001/jama.2008.615
da Silva, A. S. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2009.tde-03022010-092312
Preanalytical study of fetuin-A: effect of sample type, processing speed and freeze–thaw cycles
McArthur, L., Johnston, L., Sattar, N. A., Logue, J., & Welsh, P. I. (2014) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563214529550
Immunological and molecular mechanisms in NAFLD
Copaci, I., Micu, L., Chiriac, G., Mindrut, E., Ismail, G., & Leurzeanu, L. (2015) · Journal of Translational Medicine and Research · doi:10.21614/jtmr-20-4-57
Association of Fetuin-A with Carotid Intima-Media Thickness and Vascular Diseases
Akyüz, A. (2015) · Springer eBooks · doi:10.1007/978-94-007-7741-5_16-1
FACULTAT DE MEDICINA I ODONTOLOGÍA
Medicina, D. D. (2014)
The Role of Fetuin-A in Disease Processes Prevalent in Postmenopausal Women
Bane, A. A., & Grandjean, P. W. (2015) · Dialnet (Universidad de la Rioja)
Nichtalkoholische Steatohepatitis
Stefan, N., & Häring, H.-U. (2011) · Der Internist · doi:10.1007/s00108-010-2712-4
Self-citationBiomarkers of Diabetes and Diabetic Complications
Sen, S., Chakraborty, R., & De, B. (2016) · Springer eBooks · doi:10.1007/978-981-10-1542-7_9
de Souza, D. G., & Remy, L. (2016) · TSpace (University of Toronto)
Influence of moderate alcohol consumption on emotional and physical well-being
Schrieks, I. C. (2015) · doi:10.18174/343310
Association of Alcohol Consumption with Glucose Homeostasis: A Systematic Review and Meta-analysis
Taghdiri, S. (2017) · TSpace (University of Toronto)
Kilavuz, A., Bağca, B. G., Savaş, S., Avci, Ç. B., Saraç, F., & Gündüz, C. (2019) · Ege Tıp Dergisi · doi:10.19161/etd.623697
Aydın, H., Tekin, Y. K., Korkmaz, İ., Eker, Z., & Demirtaş, E. (2020) · Disaster and Emergency Medicine Journal · doi:10.5603/demj.a2020.0005
Nichtalkoholische Steatohepatitis: Prädiktor und Folge des Diabetes
Stefan, N., & Häring, H. (2011) · Der Internist
Self-citationCurrent literature in diabetes
(2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.952
Márkus, B., Temesszentandrási, G., Vörös, K., Jakab, L., Fekete, B., Farkas, H., Prohászka, Z., Masszi, T., & Kalabay, L. (2022) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.2022.01744
Mühlenbruch, K., Jeppesen, C., Joost, H., Boeing, H., & Schulze, M. B. (2013) · PLoS ONE · doi:10.1371/annotation/65bd3a11-b821-4f10-88d2-29b69a730f21
Self-citationFetuin-A in patients with metabolic syndrome
Dąbrowska, A. M., Tarach, J. S., Wojtysiak-Duma, B., Malecha-Jędraszek, A., Toruń-Jurkowska, A., Kudlicki, J., & Donica, H. (2013) · Current Issues in Pharmacy and Medical Sciences · doi:10.12923/j.2084-980x/26.3/a.14
Kern-Matschilles, S., Gar, C., Schilbach, K., Haschka, S. J., Rauch, B., Then, C., Seißler, J., Bidlingmaier, M., & Lechner, A. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1850-5392
Xue, Y., Tian, M., Li, M., Jiang, X., Cao, J., Zhou, Y., Liu, Y., & Ma, H. (2023) · Research Square · doi:10.21203/rs.3.rs-3242707/v1
Ali, A., Zaki, H. H., Herzalla, M. R., Zaki, A. H., Hussein, J., Aly, O., & Hafez, M. M. (2023) · Journal of The Arab Society for Medical Research · doi:10.4103/jasmr.jasmr_3_23
Kadhim, R. S., & Hassan, F. A. (2024) · AIP conference proceedings · doi:10.1063/5.0236227
Božičević, S., Bulum, T., Duvnjak, L. S., & Lovrenčić, M. V. (2025) · Diagnostics · doi:10.3390/diagnostics15040423 · Cited by 1
Bernard, D., Sultan, A., & Bouzakri, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178182
Khaldi, R. A., Mojiminiyi, O. A., & Abdella, N. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104473
Vélayoudom‐Céphise, F. (2012) · doi:10.70675/25757912z8b37z4273zb275zcc29c39176f2
[Rôle du sytème calpaïne /calpastatine dans le remodelage cardiovasculaire]
Wan, F. (2013) · theses.fr (ABES) · doi:10.70675/0acbfc23zb828z4eb7z9d70z11fb0ac18fce
Patrier, L. (2014) · theses.fr (ABES) · doi:10.70675/856fba23zd92az4508z88b4z4a6cd1d739dd
Mori, T., Ito, H., Kozasa, T., Yukawa, C., Matsumoto, S., Inoue, H., & Antoku, S. (2026) · PLoS ONE · doi:10.1371/journal.pone.0353032
Öner-İyidoğan, Y., & Koçak, H. (2026) · Cells · doi:10.3390/cells15141262
Metabolic Regulation by Adipokines, Hepatokines, and Myokines
Stefan, N., White, M. F., & Häring, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00012-3
Self-citationAl-Shaheeb, S., & Mohammed, A. K. (2026) · Libyan International Medical University Journal · doi:10.1055/s-0046-1827456
Metadata
- Authors
- Stefan, N., Fritsche, A., Weikert, C., Boeing, H., Joost, H.-G., Häring, H.-U., & Schulze, M. B.
- Affiliations
- University of Tübingen (DE)
- German Institute of Human Nutrition (DE)
- Department of Internal Medicine, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University of Tübingen, Tübingen, Germany
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-10-01
- Volume
- 57
- Issue
- 10
- Pages
- 2762-2767
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2551687
- OpenAlex
- W2130626015
- Cited by
- 379
- References
- 32
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 15 · 2023: 14 · 2022: 15 · 2021: 13 · 2020: 18 · 2019: 13 · 2018: 26 · 2017: 26 · 2016: 26 · 2015: 31 · 2014: 28 · 2013: 34 · 2012: 28
- FWCI
- 17.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Deutsche Krebshilfe
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- fetuin-A, type 2 diabetes, diabetes risk, insulin resistance, plasma biomarkers, hyperglycemia, EPIC-Potsdam cohort
- MeSH terms
- Adult, Age Factors, Aged, Blood Proteins, Diabetes Mellitus, Type 2, Female, Germany, Humans, Life Style, Male, Middle Aged, Risk Factors, Cohort Studies, alpha-2-HS-Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review